Pathogenesis and Treatment of Pretibial Myxedema
Open Access
- 1 June 1987
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 16 (2) , 409-415
- https://doi.org/10.1016/s0889-8529(18)30486-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Generation of Insulin-Like Growth Factor-1—Sensitive Cells by Growth Hormone ActionScience, 1986
- Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: Possible functional and clinical significanceBiochemical and Biophysical Research Communications, 1986
- Chemical characterization of high buoyant density proteoglycan accumulated in the affected skin of pretibial myxedema of Graves' disease.Endocrinologia Japonica, 1986
- An ultrastructural study of pretibial myxedema utilizing improved ruthenium red stainJournal of Cutaneous Pathology, 1984
- Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' DiseaseAnnals of Internal Medicine, 1980
- Ultrastructural and Immunological Findings in Graves' Disease with Pretibial Myxedema*Journal of Cutaneous Pathology, 1980
- Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.BMJ, 1979
- Stimulation of Fibroblast Biosynthetic Activity by Serum of Patients with Pretibial MyxedemaJournal of Investigative Dermatology, 1978
- Ruthenium red and violet. II. Fine structural localization in animal tissuesThe Anatomical Record, 1971
- Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' diseaseThe American Journal of Medicine, 1967